Integra LifeSciences Holdings

Integra LifeSciences Holdings (IART) SEC filings

Integra LifeSciences Holdings (IART) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported IART revenue for 2025-09-30 was $402.1M. Net income was -$5.4M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. IART currently screens at market cap $1.32B. The IART filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Integra LifeSciences Holdings said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

0

10-K

0

10-Q

1

8-K

0

Form 4

Recent filings

8-K2.029.01

8-K exhibit

EDGAR

EDGAR is the official archive. Browse all IART filings.

Frequently asked questions

What did IART just say?

IART cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.

Where are IART SEC filings?

1 cached filing is on this page. EDGAR remains the official archive (CIK 0000917520).

What is an 8-K Item 2.02?

Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.